Skip to main content

Opinion: In mifepristone case, the Supreme Court must affirm the FDA's authority. Medical innovation is at risk

By STAT News  
   December 14, 2023

The case, the Alliance for Hippocratic Medicine v. FDA, is disguised as a dispute over safety. In reality, it's about whether the courts will go along with overturning, for political reasons, the authority of the FDA as the scientific arbiter of approval of new drugs and restrictions on their distribution.

Full story


Get the latest on healthcare leadership in your inbox.